Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-012642 General Corporate
Debt relative to revenue 25th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
200.54% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.67% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-2.03% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
65.36% · CORE · VALID
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
0.65% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin 100th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
80.96% · CORE · VALID
Operating margin 100th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
42.35% · CORE · VALID
R&D intensity 0th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
24.08% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.06% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 93.71%
Current 200.54%
Delta 106.83% Capex Intensity Decreased
Previous 1.74%
Current 0.67%
Delta -1.07% Cash Generation Decreased
Previous 2.55%
Current -2.03%
Delta -4.58% Growth Increased
Previous -10.19%
Current 65.36%
Delta 75.55% Margin Increased
Previous 67.68%
Current 80.96%
Delta 13.28% Profitability Increased
Previous -9.24%
Current 42.35%
Delta 51.58% R And D Intensity Decreased
Previous 41.88%
Current 24.08%
Delta -17.81% Sbc Intensity Decreased
Previous 13.84%
Current 6.06%
Delta -7.79% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.